LOSI, Lorena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.101
EU - Europa 14.343
AS - Asia 8.694
SA - Sud America 1.209
AF - Africa 170
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 45.541
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.839
IT - Italia 6.863
GB - Regno Unito 3.250
SG - Singapore 3.115
CN - Cina 2.233
HK - Hong Kong 1.013
BR - Brasile 904
VN - Vietnam 890
SE - Svezia 840
DE - Germania 752
FR - Francia 418
FI - Finlandia 412
UA - Ucraina 371
RU - Federazione Russa 367
NL - Olanda 323
TR - Turchia 276
KR - Corea 201
IN - India 199
BG - Bulgaria 154
ID - Indonesia 133
BD - Bangladesh 118
AR - Argentina 117
CA - Canada 117
MX - Messico 91
AL - Albania 80
PL - Polonia 78
ES - Italia 73
IQ - Iraq 73
AE - Emirati Arabi Uniti 68
JP - Giappone 64
ZA - Sudafrica 56
BE - Belgio 49
PK - Pakistan 48
IE - Irlanda 47
LT - Lituania 43
RO - Romania 43
CL - Cile 37
EC - Ecuador 35
MY - Malesia 35
CH - Svizzera 32
UZ - Uzbekistan 30
CO - Colombia 29
PH - Filippine 25
VE - Venezuela 23
MA - Marocco 22
CZ - Repubblica Ceca 20
NP - Nepal 19
PY - Paraguay 19
IL - Israele 18
KE - Kenya 18
JO - Giordania 17
LV - Lettonia 17
SA - Arabia Saudita 16
UY - Uruguay 16
AT - Austria 15
PE - Perù 15
EG - Egitto 14
DK - Danimarca 13
PT - Portogallo 13
TH - Thailandia 13
TN - Tunisia 13
BO - Bolivia 12
DZ - Algeria 12
AU - Australia 11
BY - Bielorussia 11
ET - Etiopia 11
IR - Iran 11
KZ - Kazakistan 11
TW - Taiwan 11
AZ - Azerbaigian 10
CR - Costa Rica 9
GR - Grecia 9
PS - Palestinian Territory 8
DO - Repubblica Dominicana 7
KG - Kirghizistan 7
MD - Moldavia 7
NO - Norvegia 7
SI - Slovenia 7
HU - Ungheria 6
PA - Panama 6
RS - Serbia 6
BZ - Belize 5
GT - Guatemala 5
JM - Giamaica 5
PR - Porto Rico 5
QA - Qatar 5
LK - Sri Lanka 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
CG - Congo 3
EE - Estonia 3
EU - Europa 3
GA - Gabon 3
GE - Georgia 3
HN - Honduras 3
LB - Libano 3
MT - Malta 3
NZ - Nuova Zelanda 3
Totale 45.490
Salva come PNG Salva come JPEG
Città #
Southend 2.496
Singapore 2.009
Santa Clara 1.716
Ashburn 1.672
Fairfield 1.665
Woodbridge 1.129
Chicago 1.001
Hong Kong 998
Chandler 940
Houston 828
Jacksonville 680
Seattle 664
Wilmington 650
Los Angeles 643
Rome 602
Hefei 601
Cambridge 591
San Jose 583
Dearborn 574
Ann Arbor 532
Nyköping 485
Salt Lake City 441
Beijing 423
Milan 422
London 370
Modena 338
Ho Chi Minh City 273
Helsinki 261
New York 243
Elk Grove Village 215
Tampa 210
Hanoi 208
Council Bluffs 202
The Dalles 198
Seoul 191
Naples 175
San Diego 175
Shanghai 162
Princeton 157
Bologna 148
Izmir 145
Dallas 141
Sofia 140
Frankfurt am Main 134
Eugene 130
Sterling 125
Lauterbourg 122
Lancaster 113
Turin 112
Bari 109
São Paulo 103
Moscow 102
Buffalo 94
Jakarta 91
Florence 86
Palermo 86
Munich 83
Bremen 77
Cagliari 69
Parma 66
Tirana 65
Verona 65
Des Moines 64
Columbus 63
Detroit 63
Miami 63
Orem 63
Dulles 60
Phoenix 60
Reggio Emilia 58
Tokyo 56
Warsaw 55
Perugia 54
Da Nang 53
Boardman 51
Redwood City 51
Catania 50
Fremont 47
Dublin 44
Atlanta 42
Denver 42
Padova 41
Pescara 40
Toronto 38
Brussels 37
Chennai 37
Genoa 37
Stockholm 35
Brooklyn 34
Trieste 34
Falls Church 33
Haiphong 33
Rio de Janeiro 33
Guangzhou 32
Kansas City 32
Montreal 31
Pittsburgh 31
Brescia 30
Nanjing 29
Napoli 28
Totale 29.813
Salva come PNG Salva come JPEG
Nome #
Robbins e Cotran Atlante di Anatomia Patologica 6.377
Exome sequencing and bioinformatic approaches reveals rare sequence variants involved in cell signalling and elastic fibre homeostasis: new evidence in the development of ectopic calcification 505
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 443
LonP1 Differently Modulates Mitochondrial Function and Bioenergetics of Primary Versus Metastatic Colon Cancer Cells 439
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 436
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA) 436
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 433
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-asociated polyposis pedigrees 423
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 406
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas 403
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 401
DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM) 401
Assessment of K-ras, Smad4 and p53 gene alterations in colorectal metastases and their role in the metastatic process 398
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 397
Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells. 394
K-ras and p53 mutations in human colorectal aberrant crypt foci 388
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 383
Microsatellite instability in multiple colorectal tumors 380
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 380
Down-regulation of μ-protocadherin expression is a common event in colorectal carcinogenesis 379
Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions RID B-2583-2012 372
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 372
Brooke-Spiegler syndrome: Report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes 369
Repurposing of drugs targeting yap-tead functions 367
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 366
Aetiology of colorectal cancer and relevance of monogenic inheritance. 365
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 361
Preoperative Therapy for Lower Rectal Cancer and Modifications in Distance From Anal Sphincter 359
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 358
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 357
Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer 356
Aberrant crypt foci in patients with colorectal cancer 355
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 353
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 352
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 349
Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells 348
Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool 346
Prognostic significance of K-ras mutations in colorectal carcinoma. 339
Loss of Smad4 expression predicts liver metastasis in human colorectal cancer 336
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 336
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 335
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 334
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 334
Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines 332
Histology of aberrant crypt foci in the human colon 329
Expression of p53 protein in prostate cancers of different histologic types. 329
Promoter Methylation and Down-regulated Expression of the TBX15 Gene in Ovarian Carcinoma 326
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 325
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 319
Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers 318
Stability of K-ras mutations throughout the natural history of human colorectal cancer. 314
Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma 308
MELANOSIS (PIGMENTED MELANOCYTOSIS) OF THE PROSTATE GLAND. 307
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 305
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting 304
Deep learning techniques for detecting preneoplastic and neoplastic lesions in human colorectal histological images 303
Paneth and argyrophil cells in prostatic carcinoma. 302
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 301
Loss of expression of μ-protocadherin and protocadherin-24 in sporadic and hereditary nonpolyposis colorectal cancers 292
Microsatellite instability and colorectal cancer prognosis. 291
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 289
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 289
Desmoplastic melanoma: a challenge for the oncologist 288
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. 284
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer 282
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 282
Primary mucinous (so-called colloid) carcinomas of the lung - A clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression 281
Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer 276
Prognostic value of "Dworak" tumor regression grade (TRG) after pre-operative chemo-radiotherapy in rectal cancer (RC) 269
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 269
Evolution of intratumoral genetic heterogeneity during colorectal cancer progression 267
Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. 266
Colorectal carcinoma in different age groups: A population based investigation 264
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 264
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 264
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 262
Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells 261
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 261
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 260
Regenerative Medicine of Epithelia: Lessons From the Past and Future Goals 260
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 257
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 255
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 253
Biological characterization of mucinous carcinoma of the colon and rectum 253
Can immunohistochemistry improve the pathological diagnosis of placenta accreta spectrum (PAS) disorders? 248
Malignant peritoneal mesothelioma in a woman with bilateral ovarian serous borderline tumour: Potential interactions between the two diseases 245
High Expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells 240
CDX-2 homeobox gene and MUC2 expression identifies true mucinous (so-called colloid) carcinoma of the lung and justifies its indolent outcome 238
Alternative marker panel for Microsatellite Instability analysis in deection of contitutional MLH1 and MSH2 mutations. 236
TERT promoter methylation and protein expression as predictive biomarkers for recurrence risk in patients with serous borderline ovarian tumours 233
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 230
Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. 228
Myxoid metastases of melanoma: report of three cases and review of the literature 224
Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC". A population-based study in Northern Italy. Colorectal Cancer Study Group. 223
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 222
Survival for colon and rectal cancer in a population-based cancer registry 222
Pigment epithelial-derived factor: a new player in dermal elastic fibre calcification? 222
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization 220
Cadherins down-regulation: towards a better understanding of their relevance in colorectal cancer 217
Mesalazine inhibits the beta-catenin signalling pathway acting through the upregulation of mu-protocadherin gene in colo-rectal cancer cells 214
Totale 37.744
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.699
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021898 0 0 0 0 0 0 0 0 0 432 243 223
2021/20223.358 134 361 305 241 124 176 224 201 359 225 649 359
2022/20233.584 377 366 236 330 371 456 148 356 401 119 215 209
2023/20243.619 187 202 247 363 571 310 287 376 152 288 262 374
2024/20258.195 314 144 308 676 1.443 1.094 640 541 969 413 725 928
2025/202614.380 813 550 917 2.524 4.435 907 1.425 607 1.269 933 0 0
Totale 45.778